Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-11-039682
Filing Date
2011-08-04
Accepted
2011-08-04 16:09:19
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 POZEN INC. 10-Q 6-30-2011 form10-q.htm 10-Q 917096
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 15828
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 15562
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 8305
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 7976
  Complete submission text file 0001140361-11-039682.txt   2712470

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pozn-20110630.xml EX-101.INS 389039
7 XBRL TAXONOMY SCHEMA DOCUMENT pozn-20110630.xsd EX-101.SCH 7705
8 XBRL TAXONOMY CALCULATION LINKBASE DOCUMENT pozn-20110630_cal.xml EX-101.CAL 27063
9 XBRL TAXONOMY LABEL LINKBASE DOCUMENT pozn-20110630_lab.xml EX-101.LAB 99969
10 XBRL TAXONOMY PRESENTATION LINKBASE DOCUMENT pozn-20110630_pre.xml EX-101.PRE 57971
Mailing Address 1414 RALEIGH ROAD SUITE 400 CHAPEL HILL NC 27517
Business Address 1414 RALEIGH ROAD SUITE 400 CHAPEL HILL NC 27517 919-913-1030
POZEN INC /NC (Filer) CIK: 0001059790 (see all company filings)

EIN.: 621657552 | Fiscal Year End: 0919
Type: 10-Q | Act: 34 | File No.: 000-31719 | Film No.: 111010607
SIC: 2834 Pharmaceutical Preparations